Claims for Patent: 10,512,603

Summary for Patent: 10,512,603

Title:	Ferment extract of Eupenicillium crustaceum and cosmetic use thereof
Abstract:	A ferment extract from a bacterial strain the Eupenicillium crustaceum species useful in the cosmetic treatment and/or care of the skin, mucous membranes, hair and/or nails and cosmetic uses of same.
Inventor(s):	Alminana Domenech; N ria (Barcelona, ES), Soley Astals; Albert (Barcelona, ES), Garcia Sanz; Nuria (Alicante, ES), Mola Llobera; Gemma (Barcelona, ES), Darias; Jose (La Laguna, ES), Cueto; Mercedes (La Laguna, ES)
Assignee:	LUBRIZOL ADVANCED MATERIALS, INC. (Cleveland, OH)
Application Number:	15/555,166
Patent Claims:	1. A cosmetic composition comprising a cosmetically effective quantity of a ferment extract from a strain of a Eupenicillium crustaceum species, and at least one cosmetically acceptable excipient, adjuvant and/or ingredient, wherein the ferment extract is produced by fermenting a strain of Eupenicillium crustaceum species in an aqueous culture medium and isolating the ferment extract from the aqueous culture medium or from cells of the Eupenicillium crustaceum species which have been separated out from the aqueous culture medium, wherein the ferment extract comprises relative species percentages of: 31 to 79 of peptides, 1 to 8% of free amino acids, 10 to 27% of carbohydrates, and 15 to 40% of lipids, with the condition that a sum of the percentages does not exceed 100%, and wherein the ferment extract is incorporated into a cosmetically acceptable delivery system or sustained release system selected from the group consisting of liposomes, mixed liposomes, oleosomes, niosomes, ethosomes, milliparticles, microparticles, nanoparticles and solid lipid nanoparticles, nanostructured lipid carriers, sponges, cyclodextrins, vesicles, micelles, mixed micelles of surfactants, surfactant-phospholipid mixed micelles, millispheres, microspheres and nanospheres, lipospheres, millicapsules, microcapsules, nanocapsules, microemulsions and nanoemulsions or is adsorbed on a solid organic polymer or solid mineral support selected from the group consisting of talc, bentonite, silica, starch and maltodextrin. 2. A cosmetic composition comprising a cosmetically effective quantity of a ferment extract from a strain of a Eupenicillium crustaceum species, and at least one cosmetically acceptable excipient, adjuvant and/or ingredient, wherein the ferment extract is produced by fermenting a strain of Eupenicillium crustaceum species in an aqueous culture medium and isolating the ferment extract from the aqueous culture medium or from cells of the Eupenicillium crustaceum species which have been separated out from the aqueous culture medium, wherein the extract comprises relative species percentages of: 31 to 79% of peptides, 1 to 8% of free amino acids, 10 to 27% of carbohydrates, and 15 to 40% of lipids, with the condition that a sum of the percentages does not exceed 100%, and wherein the composition is present in a formulation selected from the group consisting of multiple emulsions, liquid crystals, anhydrous compositions, oils, milks, balsams, foams, aqueous or oily lotions, aqueous or oily gels, creams, solutions, hydroalcoholic solutions, hydroglycolic solutions, hydrogels, liniments, sera, soaps, shampoos, conditioners, face masks, hairsprays, serums, polysaccharide films, ointments, mousses, pomades, pastes, powders, bars, pencils, sprays and aerosols. 3. A fabric, non-woven fabric, or medical device incorporating the cosmetic composition according to claim 1. 4. A composition according to claim 1, wherein said excipient, adjuvant and/or ingredient is selected from the group consisting of agents which diminish the sebum production, anti-seborrheic agents, mattifying agents, anti-acne agents, agents stimulating the synthesis of dermal or epidermal macromolecules and/or capable of inhibiting or preventing their degradation, collagen synthesis-stimulating agents, elastin synthesis-stimulation agents, decorin synthesis-stimulation agents, laminin synthesis-stimulation agents, defensin synthesis-stimulating agents, chaperone synthesis-stimulating agents, cAMP synthesis-stimulating agents, agents that modulate AQP-3, agents that modulate aquaporin synthesis, proteins from the aquaporin family, hyaluronic acid synthesis-stimulating agents, glycosaminoglycan synthesis-stimulating agents, fibronectin synthesis-stimulating agents, sirtuin synthesis-stimulating agents, heat shock proteins, heat shock protein synthesis-stimulating agents, agents which inhibit neuronal exocytosis, other anticholinergic agents, agents which inhibit muscular contraction, anti-aging agents, anti-wrinkle agents, antiperspirant agents, anti-inflammatory agents and/or analgesics, anti-itching agents, calming agents, anesthetic agents, inhibitors of acetylcholine-receptor aggregation, agents that inhibit acetylcholinesterase, skin relaxant agents, melanin synthesis stimulating or inhibiting agents, whitening or depigmenting agents, propigmenting agents, self-tanning agents, NO-synthase inhibiting agents, 5.alpha.-reductase inhibiting agents, lysyl- and/or prolyl hydroxylase inhibiting agents, antioxidants, free radical scavengers and/or agents against atmospheric pollution, reactive carbonyl species scavengers, anti-glycation agents, antihistamine agents, antiviral agents, antiparasitic agents, emulsifiers, emollients, organic solvents, liquid propellants, skin conditioners, humectants, substances that retain moisture, alpha hydroxy acids, beta hydroxy acids, moisturizers, epidermal hydrolytic enzymes, vitamins, amino acids, proteins, pigments or colorants, dyes, biopolymers, gelling polymers, thickeners, surfactants, softening agents, emulsifiers, binding agents, preservatives, agents able to reduce or treat the bags under the eyes, exfoliating agents, keratolytic agents, desquamating agents, antimicrobial agents, antifungal agents, fungistatic agents, bactericidal agents, bacteriostatic agents, agents stimulating the synthesis of lipids and components of the stratum corneum, ceramides, fatty acids, agents that inhibit collagen degradation, agents that inhibit matrix metalloproteinases, agents that inhibit elastin degradation, agents that inhibit serine proteases, agents stimulating fibroblast proliferation, agents stimulating keratinocyte proliferation, agents stimulating adipocyte proliferation, agents stimulating melanocyte proliferation, agents stimulating keratinocyte differentiation, agents stimulating or delaying adipocyte differentiation, antihyperkeratosis agents, comedolytic agents, anti-psoriasis agents, DNA repair agents, DNA protecting agents, stem cell protecting agents, stabilizers, agents for the treatment and/or care of sensitive skin, firming agents, anti-stretch mark agents, binding agents, lipolytic agents or agents stimulating lipolysis, adipogenic agents, agents modulating PGC-1 .alpha. expression, agents modulating the activity of PPAR.gamma., agents which increase or reduce the triglyceride content of adipocytes, anti-cellulite agents, agents which inhibit the activity of PAR-2, agents stimulating healing, coadjuvant healing agents, agents stimulating reepithelialization, coadjuvant reepithelialization agents, cytokine growth factors, agents acting on capillary circulation and/or microcirculation, agents stimulating angiogenesis, agents that inhibit vascular permeability, venotonic agents, agents acting on cell metabolism, agents which improve dermal-epidermal junction, agents inducing hair growth, hair growth inhibiting or retardant agents, hair loss retardant agents, preservatives, perfumes, odor absorbents and/or body odor masking deodorants, chelating agents, plant extracts, essential oils, marine extracts, agents obtained from a biotechnological process, mineral salts, cell extracts, sunscreens and organic or mineral photoprotective agents active against ultraviolet A and/or B rays and/or infrared A rays, and mixtures thereof. 5. A composition according to claim 1, wherein the effective quantity of the ferment extract in the composition, based on the extract dry weight, is 0.0000000001% to 20% by weight, based on the total weight of the composition. 6. The composition according to claim 1, wherein the effective quantity of the ferment extract in the composition, based on the extract dry weight, is at least 0.00005% by weight, based on the total weight of the composition. 7. The composition according to claim 1, wherein the ferment extract comprises free amino acids, peptides, carbohydrates and lipids. 8. The composition according to claim 1, wherein the ferment extract has a molecular weight of less than 3400 Da. 9. The composition according to claim 1, wherein the strain of Eupenicillium crustaceum species is a strain with deposit number CECT 20901. 10. The composition according to claim 1, wherein the excipient, adjuvant and/or ingredient is selected from the group consisting of cosmetic carriers selected from the group consisting of peanut oil, soybean oil, mineral oil, sesame oil, castor oil, polysorbates, sorbitan esters, ether sulfates, sulfates, betaines, glycosides, maltosides, fatty alcohols, nonoxynols, poloxamers, polyoxyethylenes, polyethylene glycols, dextrose, glycerol, and digitonin; humectants selected from the group consisting of glycerin, propylene glycol, butylene glycol, pentylene glycol, caprylyl glycol, lactic acid, urea, and sodium hyaluronate; emollients and skin conditioning agents selected from dimethicone, glyceryl stearate, caprylic/capric triglyceride, cetearyl alcohol, lecithin, C12-15 alkyl benzoate, squalane, lanolin, behenyl alcohol, tocopheryl acetate, panthenol, Butyrospermum parkii butter, retinyl palmitate, and retinol; surfactants selected from the group consisting of xanthan gum, sodium laureth sulfate, stearic acid, Polysorbate 20, Polysorbate 80, stearyl alcohol, cetyl alcohol, Steareth-2, Ceteareth-20, and cocamidopropyl betaine; and agents which increase the percutaneous absorption selected from the group consisting of dimethyl sulfoxide, dimethylacetamide, dimethylformamide, surfactants, azone (1-dodecylazacycloheptane-2-one), alcohol, urea, ethoxydiglycol, acetone, propylene glycol and polyethylene glycol. 11. A composition according to claim 2, wherein the effective quantity of the ferment extract in the composition, based on the extract dry weight, is 0.0000000001% to 20% by weight, based on the total weight of the composition. 12. The composition according to claim 2, wherein the ferment extract has a molecular weight of less than 3400 Da. 13. The composition according to claim 1, wherein the aqueous culture medium has a pH of about 7.5. 14. The composition according to claim 2, wherein the aqueous culture medium has a pH of about 7.5. 15. The composition according to claim 2, wherein the strain of Eupenicillium crustaceum species is a strain of Eupenicillum crustaceum species with deposit number CECT 20901. 16. A method of treatment or care of the skin, mucous membranes, hair or nails of an individual, comprising administering the composition according to claim 1 to the skin, mucous membranes, hair or nails of the individual. 17. The method according to claim 16, wherein the treatment and/or care includes at least one of: depigmentation, whitening, or lightening in color of the skin, mucous membranes, hair and/or nails; depigmentation, whitening, or the lightening in color of age spots; the depigmentation of or the whitening or lightening in color of the skin of dark eye circles; maintenance or improvement of skin luminosity; alleviation of the symptoms of skin aging; treatment of skin wrinkles; treatment of dark under-eye circles; treatment of puffy eye; treatment of eye bags; smoothing out of or reduction of skin wrinkles; reduction in volume of a puffy eye or of eye bags; maintenance or improvement of skin elasticity; and maintenance or improvement of skin resistance, firmness or tensile strength. 18. The method according to claim 16, wherein the treatment and/or care promotes collagen production, promotes elastin production, inhibits collagenase activity, inhibits elastase activity, inhibits the production of AGEs, inhibits vascular permeability, inhibits melanin formation, inhibits tyrosinase activity and/or promotes the breakdown of bilirubin in the skin. 19. The method according to claim 16, wherein the administration comprises topical administration of the composition to the individual. 20. A method of treatment or care of the skin, mucous membranes, hair or nails of an individual, comprising administering the composition according to claim 2 to the skin, mucous membranes, hair or nails of the individual.

Details for Patent 10,512,603

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2035-03-05
Aimmune Therapeutics, Inc.	PALFORZIA	peanut (arachis hypogaea) allergen powder	Powder	125696	01/31/2020		2035-03-05